Nextcure, Inc. · NASDAQ:NXTC
Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. sold 30,000 Nextcure, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. (Former 10% Owner) sold 30,000 Nextcure, Inc. shares at US$6.16 for US$185K, leaving 308,636 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 30,000 shares
- Price
- US$6.16
- Value
- US$185K
- Holding after
- 308,636 shares (held indirectly)
- Trading plan
- No
- Role
- Former 10% Owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Sale | 30,000 | US$6.16 | 308,636 | Indirect |
Source
Related
- Nextcure, Inc.
- Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd.
- Nextcure, Inc. shareholders
- Schedule 13G · JP Sailing Capital Ltd · Oct 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026